YpsoMate On’s integrated electronics are detachable from the syringe to support recycling, re-use, or take-back.

Catch up on the biggest medtech news stories of the week in one minute or less.

A pilot study shows how a new tool can improve specific human brain functions related to self-control and mental flexibility.

The fast-growing minimally invasive glaucoma surgery (MIGS) market just got a new contender.

Cardialen has won a nod from FDA for an IDE to begin a clinical trial of its Multipulse therapy.

Although cardiac perforations are rare, FDA says the risk of major complications following cardiac perforation may be higher in patients who receive a Medtronic Micra leadless pacing system.

The London-based company said the center would be based in Munich, Germany.

HHS just withdrew a Trump Administration-established policy limiting FDA’s ability to regulate laboratory-developed tests.

Globus Medical could be looking into acquiring Nuvasive, according to a Reuters report.